While SURPASS-4 was not powered to evaluate differences in MACE-4 incidence between tirzepatide treatment groups and glargine, it was designed to fulfill the MACE-4 non-inferiority analysis requested by regulatory authorities to evaluate the cardiovascular safety of new glucose lowering medications
Do NOT exceed the recommended dose
These efforts underscore the potential of GLP-1RAs to offer novel treatment options and improve patient outcomes across a range of inflammatory diseases.
"These help to tone and firm the underlying tissue that remains after fat loss," clarifies Dr
But slowly your skin begins to itch, and the telltale signs of a rash are already popping up first on your torso, and now spreading to your arms and legs
Pancreatitis symptoms can include severe upper abdominal pain that radiates to the back, nausea and vomiting, and yes, diarrhea